Swedish-Nature-09-1248x672

iLite AAV NAb Assessment

Reliable Detection of Neutralizing Antibodies against AAV Capsids

Assay-development-504x672

Reliable Detection of AAV Neutralizing Antibodies

AAV NAb Bioassays

Detection of neutralizing antibodies (NAbs) in AAV gene therapies is essential. Our AAV NAb cell-based reporter-gene assays, based on our proprietary iLite® technology, offer the tool you need for identifying and assessing Neutralizing Antibodies against AAV capsids.

iLite AAV NAb Reporter Gene Assays

Our AAV NAb assessment bioassays are designed to evaluate the immunogenicity of AAV capsids for different serotypes in gene therapy. They use a two-cell line setup: an AAV-responsive reporter cell and packaging cells for the vector serotype.

  • Customization for any capsid – both traditional and recombinant
  • Packaging cells eliminate the need for vector production
  • Reduced incubation time for fast and high-quality results
  • "Assay-ready" format for rapid and convenient use
  • A secondary reporter gene that acts as an internal control, compensating for differences in cell number and matrix effects

Our AAV NAb Reporter-Gene Assays

QUICK SEARCH
BM6100

iLite® AAV Responsive Reporter Assay Ready Cells

Reporter cell line designed to quantify AAV vector transduction efficiency and detect NAbs that impair gene delivery

CELL-BASED
arrow
Cell-based reporter gene bioassay | Gene Therapy Bioassays | BM6100 | AAV | Cell-based reporter gene assay | Luminescence |
BM6002

iLite® AAV2 Packaging Assay Ready Cells

Engineered and optimized to produce AAV vectors of serotype 2 for use in NAb detection studies

CELL-BASED
arrow
Cell-based reporter gene bioassay | Gene Therapy Bioassays | BM6002 | AAV | Cell-based reporter gene assay | Luminescence |
BM6005

iLite® AAV5 Packaging Assay Ready Cells

Engineered and optimized to produce AAV vectors of serotype 5 for use in NAb detection studies

CELL-BASED
arrow
Cell-based reporter gene bioassay | Gene Therapy Bioassays | BM6005 | AAV | Cell-based reporter gene assay | Luminescence |
BM6006

iLite® AAV6 Packaging Assay Ready Cells

Engineered and optimized to produce AAV vectors of serotype 6 for use in NAb detection studies

CELL-BASED
arrow
Cell-based reporter gene bioassay | Gene Therapy Bioassays | BM6006 | AAV | Cell-based reporter gene assay | Luminescence |
BM6008

iLite® AAV8 Packaging Assay Ready Cells

Engineered and optimized to produce AAV vectors of serotype 8 for use in NAb detection studies

CELL-BASED
arrow
Cell-based reporter gene bioassay | Gene Therapy Bioassays | BM6008 | AAV | Cell-based reporter gene assay | Luminescence |
BM6009

iLite® AAV9 Packaging Assay Ready Cells

Engineered and optimized to produce AAV vectors of serotype 9 for use in NAb detection studies

CELL-BASED
arrow
Cell-based reporter gene bioassay | Gene Therapy Bioassays | BM6009 | AAV | Cell-based reporter gene assay | Luminescence |

Didn't find what you were looking for?

We offer products customized to your needs. Our custom iLite® reporter-gene assays can be adapted to almost any target. We also offer custom ELISA plates and other products. In addition, you can take advantage of our service offerings and let us do the work for you.

Contact Us

iLite News

previous
Introducing the new iLite® C3a Assay Ready Cells

26 JANUARY 2026

Introducing the new iLite® C3a Assay Ready Cells

Read post
Improved Speed and Accuracy in Immunogenicity Testing

25 JANUARY 2026

Improved Speed and Accuracy in Immunogenicity Testing

Read post
Transitioning to Second-Generation iLite Cells

25 JANUARY 2026

Transitioning to Second-Generation iLite Cells

Read post
next
See more news >

iLite Downloads

previous
Mechanism-linked Potency Assays Drive Gene Therapy Success

26 JANUARY 2026

Mechanism-linked Potency Assays Drive Gene Therapy Success

Read post
Cell-based Assays in Immuno-oncology: Advancing Bispecific Antibody Development

25 JANUARY 2026

Cell-based Assays in Immuno-oncology: Advancing Bispecific Antibody Development

Read post
Biosimilar Development: Experts Discuss Analytical Characterization Toolkits for Antibody Therapeutics

25 JANUARY 2026

Biosimilar Development: Experts Discuss Analytical Characterization Toolkits for Antibody Therapeuti...

Read post
next
See more downloads >

Contact our iLite team

Write us a message and a product specialist will get in touch